Indomethacin decreases insulin secretion by reducing KCa3.1 as a biomarker of pancreatic tumor and causes apoptotic cell death.

Journal of Biochemical and Molecular Toxicology
A Karatug Kacar

Abstract

Insulinomas originate from pancreatic β cells and it is the most widely known tumor. Indomethacin is a nonsteroidal anti-inflammatory drug, which is used for blocking the production of some natural substances that cause inflammation and decrease pain. In this study, I aimed to investigate the effects of indomethacin on rat insulinoma INS-1 cells. The relationship between cell death and insulin metabolism was determined with the administration of indomethacin. The cell viability by WST-1; the apoptosis and necrosis levels by ELISA kits; malondialdehyde levels by spectrophotometer; and beclin, intracellular insulin, insulin secretion, KCa3.1, insulin receptor (IR), glucose transporter type 2 (GLUT2), activating transcription factor 2 (ATF2), Elk1, c-Jun, Akt and phosphorylated ATF2, Elk1, c-Jun, Akt, intracellular betacellulin and betacellulin secretion levels by Western blot analysis investigated. The Ins1, Ins2, IR, GLUT2, ATF2, Elk1, c-Jun, Akt, and Betacellulin gene expression levels were determined by the real-time quantitative reverse transcription-polymerase chain reaction method. Apoptotic cell death was observed with the administration of indomethacin. The insulin secretion and Ins1, Ins2 gene expression levels decreased...Continue Reading

References

Oct 1, 1975·The Journal of Clinical Investigation·A H SoliJ Roth
Jun 1, 1977·The Journal of Clinical Endocrinology and Metabolism·R S BarC W Siebert
Mar 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·M F BrownerR J Fletterick
Mar 28, 1986·Clinica Chimica Acta; International Journal of Clinical Chemistry·A LedwozywA Kadziołka
Jan 1, 1974·Proceedings of the National Academy of Sciences of the United States of America·J R GavinD N Buell
Aug 1, 1974·The Journal of Clinical Investigation·R P RobertsonE L Bierman
Dec 1, 1983·The American Journal of Physiology·D GiuglianoF D'Onofrio
Nov 1, 1995·The Journal of Clinical Investigation·A De VosF Schuit
Oct 12, 1999·The American Journal of Physiology·A ThorellL J Goodyear
Dec 6, 2001·Endocrine-related Cancer·S Pelengaris, M Khan
Mar 19, 2002·The Journal of Steroid Biochemistry and Molecular Biology·Richard J SantenWei Yue
Nov 8, 2002·British Medical Bulletin·Johann S de Bono, Eric K Rowinsky
Apr 25, 2007·Apoptosis : an International Journal on Programmed Cell Death·Martin OttBoris Zhivotovsky
Sep 11, 2007·Biochemical and Biophysical Research Communications·Hiroki FujitaMatthew D Breyer
Sep 14, 2007·Archives of Physiology and Biochemistry·Shanta J PersaudPeter M Jones
Aug 21, 2008·American Journal of Physiology. Endocrinology and Metabolism·Benoit R Gauthier, Claes B Wollheim
Mar 11, 2010·Advances in Experimental Medicine and Biology·Haruo KasaiNoriko Takahashi
Apr 23, 2011·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Annika LangeTobias Lange
Dec 18, 2013·Nature Reviews. Cancer·Luis A Pardo, Walter Stühmer

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Adenoma, Islet Cell

Islet Cell Adenoma arises in the islet cells, which are insulin producing cells of the pancreas. These tumors can be either malignant or benign. Discover the latest research on Islet Cell Adenoma here.